Lucy Therapeutics
Biotechnology, Ne 53rd St, Waltham, , 98662, Massachusetts, 10455, United States, 51-200 Employees
Phone Number: 17*********
Who is LUCY THERAPEUTICS
Lucy Therapeutics is offering a differentiated and novel approach to drug discovery by drugging targets associated with early disease pathogenesis. LucyTxs unique approach recognizes that...
Read More
- Headquarters: 10455 Ne 53rd St, Waltham, Massachusetts, 98662, United States
- Date Founded: 2017
- Employees: 51-200
- Revenue: $10 Million to $25 Million
- Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 5511
Does something look wrong? Fix it. | View contact records from LUCY THERAPEUTICS
Lucy Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Lucy Therapeutics
Answer: Lucy Therapeutics's headquarters are located at Ne 53rd St, Waltham, , 98662, Massachusetts, 10455, United States
Answer: Lucy Therapeutics's phone number is 17*********
Answer: Lucy Therapeutics's official website is https://lucytherapeutics.com
Answer: Lucy Therapeutics's revenue is $10 Million to $25 Million
Answer: Lucy Therapeutics's SIC: 5511
Answer: Lucy Therapeutics has 51-200 employees
Answer: Lucy Therapeutics is in Biotechnology
Answer: Lucy Therapeutics contact info: Phone number: 17********* Website: https://lucytherapeutics.com
Answer: Lucy Therapeutics is offering a differentiated and novel approach to drug discovery by drugging targets associated with early disease pathogenesis. LucyTxs unique approach recognizes that improvement of mitochondrial function early in disease will lead to disease modification as opposed to late-stage symptomatic treatments being pursued by many others. Mitochondrial improvement effects multiple downstream effectors that are essential to disease initiation and progression. Our targets have been validated as neuroprotective in multiple animal models. Key to our strategy is a novel dosing regimen which will mimic effects known to be protective for both neurological and cardiovascular events implicated in key CNS diseases. LucyTx proposes to focus on the orphan disease Rett Syndrome for a proof of concept; we will also explore applications of our technology to Parkinsons and other CNS diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month